Neil, Jayson <br/><br/>
ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.  [electronic resource] 

 -  International journal of oncology  Mar 2016 
 - 1045-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2423 
<br/><br/><label>Standard No.: </label>10.3892/ijo.2015.3311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--chemistry<br/>Binding, Competitive<br/>Brain Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Cell Movement<br/>Cell Proliferation<br/>Cell Survival<br/>Chemotaxis<br/>Extracellular Signal-Regulated MAP Kinases--metabolism<br/>Glioblastoma--metabolism<br/>Humans<br/>Indoles--chemistry<br/>Insulin--chemistry<br/>Mechanistic Target of Rapamycin Complex 1<br/>Mechanistic Target of Rapamycin Complex 2<br/>Multiprotein Complexes--metabolism<br/>Phenotype<br/>Phosphorylation--drug effects<br/>Protein Binding<br/>Purines--chemistry<br/>S Phase<br/>Signal Transduction--drug effects<br/>Sirolimus--chemistry<br/>TOR Serine-Threonine Kinases--metabolism